F-star Therapeutics
(NASDAQ) FSTX
This security has been delisted. This page is retained for historical reference.
FSTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowFSTX Financials
Key Financial Metrics (TTM)
Gross Margin
100.00%
Operating Margin
-145.10%
Net Income Margin
-147.79%
Return on Equity
-44.74%
Return on Capital
-27.90%
Return on Assets
-25.43%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$21.18M
Operating Income
-$36.90M
EBITDA
-$44.37M
Operating Cash Flow
-$37.91M
Capital Expenditure
-$272.00K
Free Cash Flow
-$38.19M
Cash & ST Invst.
$35.57M
Total Debt
$12.68M
F-star Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$1.13M
+49.8%
Gross Profit
$1.13M
+49.8%
Gross Margin
100.00%
N/A
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
N/A
N/A
Employees
84
N/A
Net Income
-$18.47M
-71.1%
EBITDA
-$17.84M
-81.3%
Quarterly Fundamentals
Total Cash
$35.57M
-49.9%
Total Debt
$12.68M
-5.3%
Accounts Receivable
$8.15M
+320.3%
Inventory
$0.00
N/A
Long Term Debt
$10.54M
-15.1%
Short Term Debt
$2.14M
+119.4%
Return on Assets
-25.43%
N/A
Return on Invested Capital
-27.70%
N/A
Free Cash Flow
-$16.59M
-54.8%
Operating Cash Flow
-$16.55M
-54.4%